Joining a clinical trial starts with finding a study that matches your health profile, confirming you meet its eligibility requirements, and completing a screening process that typically takes one to three weeks. The largest database of trials in the United States, ClinicalTrials.gov, lists over 400,000 studies and lets you filter specifically for ones that are actively looking for participants right now. The process is more straightforward than most people expect, but there are a few steps worth understanding before you sign up.
Find Trials That Match Your Situation
ClinicalTrials.gov is the best starting point. On the search page, set the “Study Status” filter to “Recruiting and not yet recruiting studies” so you only see trials that are actually accepting people. From there, you can narrow results using several filters: condition or disease, the type of treatment being tested, your age, sex, and location (city, state, zip code, or country). If you already know the name of a specific drug or have an NCT number from a doctor or news article, you can enter that directly in the search bar.
Beyond ClinicalTrials.gov, many patient advocacy organizations maintain their own registries for specific diseases. The Cystic Fibrosis Foundation, for example, runs a patient registry, and organizations like Global Genes connect rare disease patients with research opportunities. If you have a specific condition, checking the website of the leading nonprofit or foundation for that disease can surface trials you won’t easily find through a general search.
Your own doctor is another underused resource. Oncologists, neurologists, and other specialists often know about trials at their own institution or at nearby academic medical centers before those studies gain visibility online. If you’re interested in participating, mention it at your next appointment.
Understanding Trial Phases
Not all trials are the same, and the phase of a trial tells you a lot about what to expect. Phase I trials are the earliest stage, enrolling just 20 to 80 people. The primary goal is to study the safety of a new drug or treatment and identify side effects. These trials sometimes enroll healthy volunteers rather than patients with a specific condition.
Phase II trials expand to 100 to 300 participants and focus on whether the treatment actually works, while continuing to monitor safety. Phase III trials are much larger, enrolling 1,000 to 3,000 people. They compare the new treatment against existing standard treatments to confirm effectiveness on a broader scale. These are the trials whose results most directly lead to FDA approval. Phase IV trials happen after a drug is already on the market and track its long-term safety and optimal use in the general population.
Earlier-phase trials carry more uncertainty because less is known about the treatment. Later-phase trials offer more data on what to expect but may randomly assign you to a control group that receives the standard treatment instead of the experimental one.
What Determines Your Eligibility
Every trial has a list of inclusion and exclusion criteria that define who can and cannot participate. Inclusion criteria describe what you need to have: a specific diagnosis, a certain stage of disease, sometimes even a particular genetic mutation that the drug is designed to target. Exclusion criteria describe what would disqualify you, and this is where many people get filtered out.
Common exclusion factors include other chronic conditions besides the one being studied, medications you’re currently taking that could interact with the experimental treatment, and impaired liver or kidney function. In one FDA review of 38 drug trials, more than 60 percent excluded participants based on liver enzyme levels, and 58 percent excluded based on kidney function measures. Pregnancy is frequently an exclusion factor because the physiological changes of pregnancy can alter how a drug behaves in the body.
Older adults face a particular challenge. Even when a trial doesn’t set an upper age limit, its other criteria around multiple chronic conditions and multiple medications can effectively screen out many older participants. Physical limitations that make it hard to travel to a study site can also be a barrier.
If you don’t qualify for one trial, don’t be discouraged. Eligibility criteria vary widely from study to study, and a different trial for the same condition may have broader requirements.
The Screening Process
Once you express interest in a trial, you’ll go through a screening period before you’re formally enrolled. This usually involves bloodwork, a physical examination, and sometimes imaging scans like a CT or MRI. The research team uses these results to verify that you meet the eligibility criteria and to establish baseline measurements they’ll compare against later. Expect this process to take one to three weeks, though some trials move faster and others require additional testing.
During this period, you’ll also have conversations with the study coordinator about logistics: how often you’ll need to visit the study site, whether any visits require overnight stays, and what the overall time commitment looks like. Some trials require travel or even temporary relocation, so it’s worth asking about this early.
What Informed Consent Really Means
Before you officially join any trial, you’ll sign an informed consent document. This is not a waiver of your rights. It’s a detailed explanation of everything you need to know, and federal regulations spell out exactly what it must include.
The document will cover the purpose of the research, how long your participation will last, which procedures are experimental, and any foreseeable risks or discomforts. It will also describe what benefits you might expect (if any), what alternative treatments exist outside the trial, and how your personal health records will be kept confidential. For trials involving more than minimal risk, the form must explain whether compensation or medical treatment is available if you’re injured as a result of participating.
One of the most important elements: the document must clearly state that your participation is voluntary, that you can refuse without losing any benefits you’re otherwise entitled to, and that you can withdraw at any time with no penalty. You are never locked in. If significant new findings come up during the trial that might affect your willingness to continue, the research team is required to share that information with you.
Take your time reading this document. Ask the study coordinator to explain anything that isn’t clear. You can also take it home and discuss it with family before signing.
How Safety Is Monitored
Every clinical trial in the U.S. is overseen by an Institutional Review Board, a formal committee that reviews and approves research involving human participants before it can begin. The IRB’s job is to make sure the risks to participants are minimized and that those risks are reasonable relative to the potential benefits. This review isn’t a one-time check. The IRB conducts periodic reviews throughout the trial and requires the research team to promptly report any changes in the study or unexpected problems.
The IRB also reviews the informed consent process itself to make sure participants are being properly informed. If concerns arise about how a study is being conducted, the board has the authority to observe the consent process, audit the research, or shut the study down entirely.
Costs, Insurance, and Compensation
One of the biggest questions people have is who pays for what. The general rule is that the trial sponsor (a pharmaceutical company, university, or government agency) covers the cost of the experimental treatment itself and any tests done purely for research purposes. Your regular insurance covers what it would normally cover: routine care, standard treatments, and the management of any side effects or complications.
Medicare has a specific policy on this. It covers the routine costs of qualifying clinical trials, meaning all the items and services you would typically receive even if you weren’t in a trial. It also covers the diagnosis and treatment of complications that arise from your participation. What Medicare does not cover is the investigational drug or device itself (unless it would be covered outside the trial), tests done solely for data collection that aren’t part of your clinical care, and items the research sponsor customarily provides for free.
Private insurance increasingly follows a similar model, and many states have laws requiring insurers to cover routine costs during clinical trials. Still, it’s worth calling your insurance company before enrolling to confirm what will and won’t be covered in your specific plan.
For healthy volunteers in Phase I trials, financial compensation is common. The amount varies depending on the length of the study, the number of visits, and whether overnight stays are involved. Some trials also reimburse participants for travel, parking, or meals. Ask the study coordinator upfront about compensation so you know what to expect.
Questions Worth Asking Before You Enroll
Before committing, have a detailed conversation with the study coordinator. Some practical questions to consider:
- Time commitment: How many visits are required, and how long does each one take?
- Travel: Will you need to travel to the study site, and is transportation or lodging provided?
- Side effects: What are the known risks based on earlier phases of research?
- Emergency contact: Who do you call if you experience a problem outside of business hours?
- Costs: Will you face any out-of-pocket expenses, and is compensation offered for your time?
- Results: Will you be told whether you received the experimental treatment or the control, and will you have access to the study’s findings?
- Withdrawal: What happens if you decide to stop participating partway through?
The research team expects these questions and should answer them thoroughly. If you feel pressured or can’t get clear answers, that’s a reason to look for a different trial.